Compare · head to head
Innovent Biologics vs Japan Tobacco
Japan Tobacco ranks higher overall — 360 rank 96 vs 68.
Japan Tobacco leads on Value (63 vs 40), Growth (73 vs 49) and Safety (80 vs 62). Innovent Biologics leads on Quality (67 vs 50) and Sentiment (51 vs 41).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | China | Japan |
| Sector | Health Care | Food, Drinks & Tobacco |
| Industry | Biotechnology | Tobacco |
| Size | Large | XX-Large |
| ISIN | KYG4818G1010 | JP3726800000 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 68 | 96 |
| Value | 40 | 63 |
| Quality | 67 | 50 |
| Growth | 49 | 73 |
| Safety | 62 | 80 |
| Sentiment | 51 | 41 |
| Quality details | ||
| Profitability | 60 | 62 |
| Cash Truth | 74 | 39 |
Innovent Biologics vs Samsung EpisInnovent Biologics vs CelltrionInnovent Biologics vs MesoblastInnovent Biologics vs GC BiopharmaAdd a third stock →
Full analyses: Innovent Biologics · Japan Tobacco
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100